• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Friday, March 24, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Stocks to buy in Apr 2021: SBI, Bharti Airtel, HCL Tech may rally over 30%; Nifty Dec target seen at 17,200

by The Outlooker Web Desk
April 2, 2021
in Business
0
Stocks to buy in Apr 2021: SBI, Bharti Airtel, HCL Tech may rally over 30%; Nifty Dec target seen at 17,200
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Axis Securities has maintained its December Nifty 50 index target of 17,200. Image: Reuters

BSE Sensex and Nifty 50 ended the financial year 2020-21 on a strong note, with all the sectors delivering positive returns. Among sectors, metals and IT registered the strongest gains while FMCG grew the slowest during the year. Stocks from the auto and realty sector also delivered solid returns during the fiscal. “While FY21 was very strong aided by cheap valuations and a low base but March was a mixed bag,” said Naveen Kulkarni, Chief Investment Officer, Axis Securities. In the new financial year 2021-22, the focus will remain on earnings growth and sustenance of demand momentum.

Axis Securities has maintained its December Nifty 50 index target of 17,200. The brokerage firm said that earnings growth for the entire decade from 2010-2020 was quite sluggish with an earnings CAGR of 7 per cent (doubling in 10 years). In the broader market, mid and smallcaps have outperformed the large caps by a significant margin in FY21. Domestic brokerage firm believes that this trend is likely to sustain in FY22 as well as earnings growth is expected to be very strong for the broader market.

Top stock picks:

ICICI Bank: The brokerage firm has given a target price of Rs 720, a rally of 24 per cent from the current levels. Higher loan growth, improving operating profits, strong provision buffer coupled with strong deposit franchise will help ROAE/ROAA expansion over FY22-23E for the bank.

State Bank of India: It will take SBI stock to jump 31 per cent from the previous close to hit the target price of Rs 477 pegged by Axis Securities. Among PSU banks, SBI remains the best play on the gradual recovery in the Indian economy, with a healthy PCR, robust capitalization, a strong liability franchise and an improved asset quality
outlook.

Federal Bank: The brokerage firm sees a 23 per cent rally in Federal Bank stock price, with price target of Rs 93 apiece. Axis Securities believes that key positives are increasing retail focus, strong fee income, adequate capitalisation (Tier-1 at 13%), and prudent provisioning.

Equitas Small Finance Bank: Domestic brokerage firm believes that Equitas Small Finance Bank is eligible for re-rating given its improving profitability, asset quality and return ratios. It has given a target price of Rs 72, a gain of 20 per cent from the previous close.

Varun Beverages: With business growth restoring, aided by unlocking as witnessed in Q4CY20, Axis Securities expects the current momentum to continue. The stock has a target price of Rs 1,230, implying a rally of 23 per cent from the level of Rs1,003 apiece.

Relaxo Footwear: Relaxo Footwear has maintained healthy operating cashflows, asset turns and EBITDA margins over the years making it a capital-efficient business, said the brokerage. It has a price target of Rs 1,013 apiece, gain of 15 per cent.

Camlin Fine Sciences: The brokerage firm sees an upside of 18 per cent in Camlin Fine Sciences stock, with a target price of Rs 165. CFS is one of the world’s leading and integrated manufacturers of the most preferred traditional antioxidants and vanillin and manufactures various other shelf-life solutions, aroma ingredients and performance chemicals.

Amber Enterprises: Healthy build-up for the upcoming season, government policy measures and support through the PLI scheme makes us believers in this structural long term story. It has a target price of Rs 3,658, a gain of 10 per cent.

Minda Corporation: Minda Corp would be a beneficiary of migration to BS6 as the company’s product viz., wire harness (25-30% market share) would witness a sea change in share of business both in terms of value and volume. It will need a jump of 20 per cent from the previous close to hit the target of Rs 121 apiece.

Steel Strip Wheels: The increasing contribution of high margin Al-alloy wheel rims in overall revenues to aid margin expansion. Steel Strip Wheels had reported around 7 per cent of revenues from Al-alloy wheels in FY20 and expects to take it to 25 per cent plus over a couple of years. The brokerage firm sees a 25 per cent rally in the stock with a target price of Rs 877 apiece.

Lupin: A 20 per cent upside would be needed to take it to levels of Rs 1,225 predicted by Axis Securities. The domestic formulations market in India has recorded 9.5% CAGR in 2014-19 to reach US$ 22 bn is expected to grow at 8%-11% CAGR to US$ 31-35 bn by 2040.

Tech Mahindra: Axis Securities believes that Tech Mahindra has a resilient business structure from a long term perspective. It has recommended to ‘buy’ and has assigned 14x P/E multiple to its FY23E earnings of Rs 81, which gives a target price of Rs 1,116 per share.

Bharti Airtel: Bharti Airtel reported solid numbers in Q2FY21 beating consensus estimates both on financial and operating parameters. A jump of 31 per cent will be required to touch the target price of Rs 676.

HCL Technologies: The brokerage firm has given a target price of Rs 1,088 apiece, a jump of 11 per cent. The recent deal trend continues to be healthy for HCL tech and is reflective of traction in Retail & CPG, Manufacturing and BFSI verticals.

ACC Ltd: Stock is currently trading at 8.3x CY22E and 7.14x CY23E EV/EBITDA. Axis Securities has recommended to ‘buy’ with a target price of Rs 2,100 a share valuing the company at 10x of its CY22E EV/EBITDA.

(The stock recommendations in this story are by the respective research and brokerage firm. The Outlooker Online does not bear any responsibility for their investment advice. Please consult your investment advisor before investing.)

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Danny Steele steps into lead role ofspiritual teacher Tolle in ‘Connected’

Danny Steele steps into lead role of
spiritual teacher Tolle in ‘Connected’

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
National

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India

March 24, 2023
Vandalism At Indian High Commission In London Raised In UK Parliament
National

Vandalism At Indian High Commission In London Raised In UK Parliament

March 23, 2023
Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points
National

Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

March 23, 2023
Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation
National

Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation

March 23, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
  • Vandalism At Indian High Commission In London Raised In UK Parliament
  • Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.